-The Times of India NEW DELHI: Common nutritional supplement milk you take may not be all that nutritious as an overwhelming majority of samples of milk supplied across the country failed to meet the food safety and standard norms. The Centre on Tuesday dished out startling fact about the health of milk supplied both loose or in packets and informed the Supreme Court that 68.4% of the samples collected from rural and...
More »SEARCH RESULT
Total Matching Records found : 132
Supreme Court asks state govts to curb sale of adulterated milk
-PTI NEW DELHI: The Supreme Court on Tuesday expressed concern over the sale of adulterated milk in the country, saying it is a serious issue and action needs to be taken by the state governments to curb it. "It is a very serious issue. There is no doubt that it is happening all over the country. What action is being taken by the government?" a bench of justices K S Radhakrishnan and...
More »Banned pesticide residues found in vegetable samples -KA Martin
-The Hindu Kochi: The Kerala Agricultural University has found "dangerous levels" of pesticide residue in key vegetables like cabbage, cauliflower, vegetable cowpea (achinga), amaranthus red, small red onions, tomatoes, green chillies and curry leaves, among others. The residue includes that of the banned Profenofos, which falls into the yellow category (second level of pesticides in the toxicity classification) and which has translaminar action (the toxin entering the plant system primarily by roots,...
More »We trust indian manufacturing norms: USFDA -Divya Rajagopal
-The Economic Times MUMBAI: The United States Food and Drug Administration (USFDA), widely considered the world's most stringent regulatory authority, has said India's share in generic exports to the US over the years is an indication of the good manufacturing norms practised by Indian drugmakers. As the Ranbaxy scandal threatens to tarnish India's image as a hub of manufacturing world-class generic drugs, the statement, by USFDA's spokesman Chris Kelly in an...
More »Indian pharma's generic challenge-DG Shah
-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...
More »
